Camp4 CMO awarded 215,000 stock options
Camp4 Therapeutics reported that Chief Medical Officer Yuri Maricich received a grant of stock options covering 215,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Camp4 Therapeutics reported that Chief Medical Officer Yuri Maricich received a grant of stock options covering 215,000 shares of common stock. The options have an exercise price of $4.46 per share, expire on March 31, 2036, and vest in equal monthly installments over four years from the grant date.
Insider Trade Summary
Grant/Award: 215,000 shares
Grant/Award
1 txn
Insider
Maricich Yuri
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 215,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 215,000 contracts (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 215,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.
Key Figures
Options granted: 215,000 options
Exercise price: $4.46 per share
Underlying shares: 215,000 shares
+2 more
5 metrics
Options granted
215,000 options
Stock Option (Right to Buy) granted to CMO
Exercise price
$4.46 per share
Conversion or exercise price of options
Underlying shares
215,000 shares
Common stock underlying the options
Post-grant derivative holdings
215,000 options
Total options held following transaction
Expiration date
March 31, 2036
Option expiration for granted award
Key Terms
Stock Option (Right to Buy), exercise price, vesting, underlying security, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "4.4600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying the option vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: "Common Stock""
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CAMP report for Yuri Maricich on this Form 4?
Camp4 Therapeutics reported that Chief Medical Officer Yuri Maricich received a grant of stock options for 215,000 shares. These options were awarded as a compensation-related grant, not an open-market purchase or sale, and give him the right to buy CAMP common stock at a fixed exercise price.
How many CAMP stock options were granted to Yuri Maricich and at what price?
Yuri Maricich was granted stock options covering 215,000 shares of Camp4 Therapeutics common stock. The options carry an exercise price of $4.46 per share, meaning he can purchase shares at that price once they vest and before the options expire, subject to plan terms.
When do Yuri Maricich’s CAMP stock options vest and expire?
The stock options vest in equal monthly installments over four years starting from the grant date. They have an expiration date of March 31, 2036, giving a long timeframe during which vested options may be exercised, assuming continued service and satisfaction of any plan conditions.
Did the CAMP Form 4 show any open-market buying or selling by Yuri Maricich?
The Form 4 shows a grant of derivative securities, not an open-market trade. The single reported transaction is an option award coded as a grant or other acquisition, so there were no open-market purchases or sales of CAMP common stock in this particular filing.
What is Yuri Maricich’s CAMP option position after this reported grant?
After this transaction, Yuri Maricich is shown holding 215,000 stock options directly. These options relate to 215,000 underlying shares of Camp4 Therapeutics common stock and represent his reported derivative position from this filing, subject to vesting and expiration terms under the grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
